Q3001 — Radioelements for brachytherapy, any type, each
Q3001 is a HCPCS Level II code for radioelements for brachytherapy, any type, each. It belongs to the Temporary Codes section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusC
Contractor-priced. Your MAC establishes the RVUs and the payment amount case by case, usually after reviewing documentation. There is no national amount to compute.
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for Q3001
- Long descriptor
- Radioelements for brachytherapy, any type, each
- Short descriptor
- Brachytherapy radioelements
- Added
- July 1, 2000
- BETOS
- P7A
- Pricing indicator
- 57 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Other carrier priced.
Codes adjacent to Q3001
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If Q3001 is not quite right, the correct code is very often within a few positions of it.
- Q2050Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
- Q2052Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)
- Q2053Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Q2054Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Q2055Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Q2056Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Q2057Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose
- Q2058Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion
- Q3014Telehealth originating site facility fee
- Q3027Injection, interferon beta-1a, 1 mcg for intramuscular use
- Q3028Injection, interferon beta-1a, 1 mcg for subcutaneous use
- Q3031Collagen skin test
- Q4001Casting supplies, body cast adult, with or without head, plaster
- Q4002Cast supplies, body cast adult, with or without head, fiberglass
- Q4003Cast supplies, shoulder cast, adult (11 years +), plaster
- Q4004Cast supplies, shoulder cast, adult (11 years +), fiberglass
Questions about Q3001
What is HCPCS code Q3001?
Q3001 is a HCPCS Level II code for radioelements for brachytherapy, any type, each. It sits in the Temporary Codes section.
Does Medicare cover Q3001?
The CMS HCPCS file marks Q3001 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
How is Q3001 paid under the physician fee schedule?
Q3001 carries PFS status code C. Contractor-priced. Your MAC establishes the RVUs and the payment amount case by case, usually after reviewing documentation. There is no national amount to compute.